These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 24475864
1. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR. Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864 [Abstract] [Full Text] [Related]
2. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Davenport MS, Caoili EM, Kaza RK, Hussain HK. Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733 [Abstract] [Full Text] [Related]
3. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Bashir MR, Castelli P, Davenport MS, Larson D, Marin D, Hussain HK, Jaffe TA. Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310 [Abstract] [Full Text] [Related]
7. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. McClellan TR, Motosugi U, Middleton MS, Allen BC, Jaffe TA, Miller CM, Reeder SB, Sirlin CB, Bashir MR. Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544 [Abstract] [Full Text] [Related]
8. Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging. Hayashi T, Saitoh S, Tsuji Y, Takahashi J, Tagaya N, Hiramoto M, Fukuzawa K, Tano M, Miyati T, Kumada H. Radiology; 2015 Sep; 276(3):756-65. PubMed ID: 25811243 [Abstract] [Full Text] [Related]
9. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients. Furlan A, Close ON, Borhani AA, Wu YH, Heller MT. Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725 [Abstract] [Full Text] [Related]
10. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM. Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122 [Abstract] [Full Text] [Related]
19. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma. Allen BC, Ho LM, Jaffe TA, Miller CM, Mazurowski MA, Bashir MR. AJR Am J Roentgenol; 2018 Jun; 210(6):1266-1272. PubMed ID: 29629800 [Abstract] [Full Text] [Related]
20. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method. Song JS, Choi EJ, Park EH, Lee JH. Eur Radiol; 2018 Mar; 28(3):1132-1139. PubMed ID: 28986630 [Abstract] [Full Text] [Related] Page: [Next] [New Search]